๐ Weekly Report May 31, 2026 (PDF) โ Download
๐ Podcast May 31, 2026 (MP3) โ Play & Download

๐ Weekly Report May 31, 2026 (PDF) โ Download
๐ Podcast May 31, 2026 (MP3) โ Play & Download
Allogene’s ALLO-316 Allogeneic CAR T Achieves First Durable Remissions with 31% ORR in Phase 1 Metastatic Renal Cell Carcinoma Trial
Novel Stem Cell Approach Aims for Functional Cure in Diabetes, Pioneering Immunosuppression-Free Islet Cell Transplantation
Kite and BBG Advanced Therapies Launch Mobile Leukapheresis Center in Texas to Enhance CAR T-Cell Therapy Patient Access and Streamline Supply Chain